Patients’ Information Needs for Informed Consent to Participate in First‐in‐Human Pig Kidney Xenotransplant Clinical Trials: A Mixed Methods Study
Open Access
- 1 January 2025
- journal article
- Published by Wiley in Xenotransplantation
- Vol. 32 (1) , e70016
Abstract
Background: Transplant programs preparing to initiate first‐in‐human pig kidney xenotransplant clinical trials must be especially careful when obtaining participants’ informed consent. Little is known about the kind of information patients want for making an informed decision about trial participation. Methods: We conducted semi‐structured telephone interviews with waitlisted kidney transplant patients about information needs regarding participating in a first‐in‐human pig kidney xenotransplant trial, which guided development of a prototype consent form. Subsequent usability testing interviews sought patient feedback on the consent form. We analyzed qualitative data by thematic analysis and quantitative data by descriptive statistics. Results: Twenty‐eight patients participated in semi‐structured interviews; 16 patients participated in usability testing interviews. Most interview participants were male (68%, 56%), White (54%, 56%), or Black (36%, 31%), respectively. Interview participants identified five types of information needs: (1) the potential for infection contraction and transmission; (2) risks, benefits, and impact of xenotransplant trials; (3) xenotransplant clinical trial and recipient experience; (4) clinical trial logistics; and (5) the pig and its kidney. Usability testing participants suggested adding details to the prototype. Participants’ preparedness to make a decision about participating in a xenotransplant trial increased after reviewing the prototype (12.5% vs. 31.3%, n.s.). Conclusion: We identified multiple unique types of information patients desired to make informed decisions about pig kidney xenotransplant trial participation. Transplant programs initiating xenotransplant trials should be prepared to address patients’ information needs to optimize informed decision‐making for trial participation. The prototype consent form may support a patient‐centered approach to informed consent.Keywords
Funding Information
- National Center for Advancing Translational Sciences (R01TR003844)
This publication has 30 references indexed in Scilit:
- Informed Consent for Potential Recipients of Pig Kidney Xenotransplantation in the United StatesTransplantation, 2022
- “You cannot stay in the laboratory forever”*: Taking pig kidney xenotransplantation from the laboratory to the clinicEBioMedicine, 2021
- Transplant candidates’ perceptions of informed consent for accepting deceased donor organs subjected to intervention research and for participating in posttransplant researchAmerican Journal of Transplantation, 2019
- Infectious disease risks in xenotransplantationAmerican Journal of Transplantation, 2018
- An exploration of the relationship between families of deceased organ donors and transplant recipients: A systematic review and qualitative synthesisHealth Psychology Open, 2018
- Using the Consolidated Framework for Implementation Research (CFIR) to produce actionable findings: a rapid-cycle evaluation approach to improving implementationImplementation Science, 2017
- Standards for Reporting Qualitative ResearchAcademic Medicine, 2014
- Disclosure, Consent, and the Exercise of Patient Autonomy in Surgical Innovation: A Systematic Content Analysis of the Conceptual LiteratureAccountability in Research, 2014
- Qualitative Data Analysis for Health Services Research: Developing Taxonomy, Themes, and TheoryHealth Services Research, 2007
- Ethics of Phase 1 Oncology StudiesJAMA, 2003